Researchers have been excited about the medication , a novel dual compound showing significant outcomes in early trials for weight loss . It acts by targeting both systems: GLP-1 and GIP, which , when https://fannielaqi638343.pointblog.net/this-new-prospect-for-weight-loss-92118786